Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response
- Publisher
- CANCER RESEARCH AND TREATMENT
- Language
- 영어
- ISSN
- 1598-2998
- Citation Volume
- 52
- Citation Number
- 2
- Citation Start Page
- 594
- Citation End Page
- 603
-
Appears in Collections:
- Medicine > Medicine
- Authorize & License
-
- Files in This Item:
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.